

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 7.18122288 |
| 2 | viral transcription (GO:0019083) | 6.79876607 |
| 3 | DNA deamination (GO:0045006) | 6.62420331 |
| 4 | translational termination (GO:0006415) | 6.57434388 |
| 5 | ribosomal small subunit biogenesis (GO:0042274) | 6.21142649 |
| 6 | GDP-mannose metabolic process (GO:0019673) | 6.15172319 |
| 7 | translational elongation (GO:0006414) | 5.76286982 |
| 8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.72895602 |
| 9 | cotranslational protein targeting to membrane (GO:0006613) | 5.60894657 |
| 10 | protein targeting to ER (GO:0045047) | 5.58325846 |
| 11 | maturation of SSU-rRNA (GO:0030490) | 5.50745852 |
| 12 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 5.42432578 |
| 13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.30534223 |
| 14 | protein localization to endoplasmic reticulum (GO:0070972) | 5.30227738 |
| 15 | viral life cycle (GO:0019058) | 5.18361820 |
| 16 | cellular protein complex disassembly (GO:0043624) | 5.10699889 |
| 17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.03682931 |
| 18 | translational initiation (GO:0006413) | 5.03303720 |
| 19 | ribosomal large subunit biogenesis (GO:0042273) | 4.71366093 |
| 20 | protein complex disassembly (GO:0043241) | 4.41886564 |
| 21 | proline biosynthetic process (GO:0006561) | 4.41102852 |
| 22 | macromolecular complex disassembly (GO:0032984) | 4.21902118 |
| 23 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.16013474 |
| 24 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.15674171 |
| 25 | translation (GO:0006412) | 4.14691031 |
| 26 | NADH metabolic process (GO:0006734) | 4.12437329 |
| 27 | protein maturation by protein folding (GO:0022417) | 4.07602395 |
| 28 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.07027993 |
| 29 | proteasome assembly (GO:0043248) | 4.06011566 |
| 30 | amyloid precursor protein catabolic process (GO:0042987) | 4.00742206 |
| 31 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.97848333 |
| 32 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.86688792 |
| 33 | formation of translation preinitiation complex (GO:0001731) | 3.85227612 |
| 34 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.75364780 |
| 35 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.71250864 |
| 36 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.70785352 |
| 37 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.68664400 |
| 38 | DNA strand elongation (GO:0022616) | 3.67708798 |
| 39 | UTP biosynthetic process (GO:0006228) | 3.64995060 |
| 40 | protein targeting to membrane (GO:0006612) | 3.64861522 |
| 41 | pentose metabolic process (GO:0019321) | 3.62511548 |
| 42 | histone arginine methylation (GO:0034969) | 3.55729331 |
| 43 | rRNA processing (GO:0006364) | 3.51115890 |
| 44 | mRNA catabolic process (GO:0006402) | 3.50623620 |
| 45 | GTP biosynthetic process (GO:0006183) | 3.45801957 |
| 46 | pseudouridine synthesis (GO:0001522) | 3.45156504 |
| 47 | cellular component biogenesis (GO:0044085) | 3.42135109 |
| 48 | protein retention in ER lumen (GO:0006621) | 3.37981930 |
| 49 | DNA replication initiation (GO:0006270) | 3.37947713 |
| 50 | amyloid precursor protein metabolic process (GO:0042982) | 3.36507322 |
| 51 | rRNA metabolic process (GO:0016072) | 3.35775661 |
| 52 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.34471481 |
| 53 | ATP synthesis coupled proton transport (GO:0015986) | 3.34471481 |
| 54 | telomere maintenance via recombination (GO:0000722) | 3.34426359 |
| 55 | RNA catabolic process (GO:0006401) | 3.33766273 |
| 56 | mitochondrial fusion (GO:0008053) | 3.31753226 |
| 57 | UTP metabolic process (GO:0046051) | 3.31048969 |
| 58 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.30528332 |
| 59 | apoptotic process involved in morphogenesis (GO:0060561) | 3.30480440 |
| 60 | peptidyl-arginine N-methylation (GO:0035246) | 3.29027033 |
| 61 | peptidyl-arginine methylation (GO:0018216) | 3.29027033 |
| 62 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.22241082 |
| 63 | response to interferon-beta (GO:0035456) | 3.22215270 |
| 64 | sulfur amino acid catabolic process (GO:0000098) | 3.20693063 |
| 65 | ribosome biogenesis (GO:0042254) | 3.19235811 |
| 66 | spliceosomal snRNP assembly (GO:0000387) | 3.17632170 |
| 67 | CTP metabolic process (GO:0046036) | 3.14952804 |
| 68 | CTP biosynthetic process (GO:0006241) | 3.14952804 |
| 69 | IMP biosynthetic process (GO:0006188) | 3.13930865 |
| 70 | proline metabolic process (GO:0006560) | 3.12099987 |
| 71 | DNA replication checkpoint (GO:0000076) | 3.11014468 |
| 72 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.07448991 |
| 73 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.07329461 |
| 74 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.06401708 |
| 75 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.06291912 |
| 76 | nuclear envelope reassembly (GO:0031468) | 3.05549209 |
| 77 | mitotic nuclear envelope reassembly (GO:0007084) | 3.05549209 |
| 78 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.05503387 |
| 79 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.04039411 |
| 80 | regulation of translational fidelity (GO:0006450) | 3.01881079 |
| 81 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.00925904 |
| 82 | folic acid metabolic process (GO:0046655) | 3.00490292 |
| 83 | termination of RNA polymerase III transcription (GO:0006386) | 2.98514366 |
| 84 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.98514366 |
| 85 | protein insertion into membrane (GO:0051205) | 2.98473709 |
| 86 | purine-containing compound salvage (GO:0043101) | 2.98422476 |
| 87 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.96785227 |
| 88 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.96168874 |
| 89 | nucleobase biosynthetic process (GO:0046112) | 2.95033516 |
| 90 | regulation of protein heterodimerization activity (GO:0043497) | 2.94231262 |
| 91 | respiratory electron transport chain (GO:0022904) | 2.94223807 |
| 92 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.93709306 |
| 93 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.93611199 |
| 94 | establishment of integrated proviral latency (GO:0075713) | 2.93033102 |
| 95 | regulation of mitochondrial translation (GO:0070129) | 2.91845113 |
| 96 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.91679616 |
| 97 | telomere maintenance via telomere lengthening (GO:0010833) | 2.91230869 |
| 98 | nucleotide salvage (GO:0043173) | 2.90488630 |
| 99 | mitotic recombination (GO:0006312) | 2.90178904 |
| 100 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.89965190 |
| 101 | electron transport chain (GO:0022900) | 2.88318264 |
| 102 | rRNA transcription (GO:0009303) | 2.87652952 |
| 103 | desmosome organization (GO:0002934) | 2.87279538 |
| 104 | oxidative phosphorylation (GO:0006119) | 2.87151036 |
| 105 | IMP metabolic process (GO:0046040) | 2.86429418 |
| 106 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.85795847 |
| 107 | COPI coating of Golgi vesicle (GO:0048205) | 2.85582969 |
| 108 | Golgi transport vesicle coating (GO:0048200) | 2.85582969 |
| 109 | DNA unwinding involved in DNA replication (GO:0006268) | 2.85343555 |
| 110 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.84599845 |
| 111 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.82426273 |
| 112 | mannose metabolic process (GO:0006013) | 2.82282228 |
| 113 | monosaccharide biosynthetic process (GO:0046364) | 2.82233989 |
| 114 | viral mRNA export from host cell nucleus (GO:0046784) | 2.81600259 |
| 115 | rRNA modification (GO:0000154) | 2.81046936 |
| 116 | glucose catabolic process (GO:0006007) | 2.78585974 |
| 117 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.77634393 |
| 118 | glucose 6-phosphate metabolic process (GO:0051156) | 2.77168408 |
| 119 | negative regulation of cell size (GO:0045792) | 2.76837935 |
| 120 | gluconeogenesis (GO:0006094) | 2.76501367 |
| 121 | hexose biosynthetic process (GO:0019319) | 2.74745247 |
| 122 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.74598244 |
| 123 | heme biosynthetic process (GO:0006783) | 2.74009569 |
| 124 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.72894376 |
| 125 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.72894376 |
| 126 | oxaloacetate metabolic process (GO:0006107) | 2.72174279 |
| 127 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.71552304 |
| 128 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.71315490 |
| 129 | establishment of protein localization to mitochondrion (GO:0072655) | 2.71125945 |
| 130 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.70857919 |
| 131 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.70674323 |
| 132 | protein targeting to mitochondrion (GO:0006626) | 2.70302748 |
| 133 | metallo-sulfur cluster assembly (GO:0031163) | 2.70208014 |
| 134 | iron-sulfur cluster assembly (GO:0016226) | 2.70208014 |
| 135 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.69953332 |
| 136 | urea cycle (GO:0000050) | 2.69710041 |
| 137 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.69481935 |
| 138 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.69338806 |
| 139 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.69245768 |
| 140 | negative regulation of ligase activity (GO:0051352) | 2.69245768 |
| 141 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.68401680 |
| 142 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.68401680 |
| 143 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.68401680 |
| 144 | purine nucleotide salvage (GO:0032261) | 2.67469974 |
| 145 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.67133519 |
| 146 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.67133519 |
| 147 | transcription from mitochondrial promoter (GO:0006390) | 2.67127328 |
| 148 | deoxyribonucleotide catabolic process (GO:0009264) | 2.67092231 |
| 149 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.66948730 |
| 150 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.66626236 |
| 151 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.64532275 |
| 152 | pentose-phosphate shunt (GO:0006098) | 2.63999976 |
| 153 | spliceosomal complex assembly (GO:0000245) | 2.63336416 |
| 154 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.62671176 |
| 155 | respiratory chain complex IV assembly (GO:0008535) | 2.62471885 |
| 156 | L-phenylalanine metabolic process (GO:0006558) | 2.61654901 |
| 157 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.61654901 |
| 158 | ncRNA processing (GO:0034470) | 2.60730357 |
| 159 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.60440035 |
| 160 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.60440035 |
| 161 | protein localization to mitochondrion (GO:0070585) | 2.59762253 |
| 162 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.59641065 |
| 163 | prostaglandin biosynthetic process (GO:0001516) | 2.59636301 |
| 164 | prostanoid biosynthetic process (GO:0046457) | 2.59636301 |
| 165 | establishment of protein localization to membrane (GO:0090150) | 2.59303374 |
| 166 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.58824746 |
| 167 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.58740459 |
| 168 | ncRNA 3-end processing (GO:0043628) | 2.57479736 |
| 169 | peptidyl-histidine modification (GO:0018202) | 2.54228955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.56579860 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.43219935 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.32179745 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.05818672 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.03159061 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.00040756 |
| 7 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.94952247 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.93051195 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.89539447 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.85848863 |
| 11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.76577421 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.66188188 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.60435658 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.60168492 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.57565686 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.55215489 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.48990090 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.45947092 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.33285448 |
| 20 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.30830178 |
| 21 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.30821514 |
| 22 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29697227 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.23999587 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.23229319 |
| 25 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.21754106 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14075229 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.09421338 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.06664331 |
| 29 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.06325612 |
| 30 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.05904919 |
| 31 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.01535080 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.00291817 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.99909646 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.90238424 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.85267102 |
| 36 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.84455706 |
| 37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.83047548 |
| 38 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.82222357 |
| 39 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.81522132 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.79988002 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79683555 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.77723266 |
| 43 | P68_20966046_ChIP-Seq_HELA_Human | 1.77411757 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77378917 |
| 45 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.75474447 |
| 46 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.73901908 |
| 47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.71996386 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66843869 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66743349 |
| 50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.64372925 |
| 51 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.64029960 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63836404 |
| 53 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.60503767 |
| 54 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.60411674 |
| 55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57982474 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.57897535 |
| 57 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57887057 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57607051 |
| 59 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.55068925 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.54600895 |
| 61 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.52745190 |
| 62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52660187 |
| 63 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.52407749 |
| 64 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50615721 |
| 65 | MYC_22102868_ChIP-Seq_BL_Human | 1.47413614 |
| 66 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.46795233 |
| 67 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.45507405 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45506091 |
| 69 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.45498776 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.43714461 |
| 71 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.43133628 |
| 72 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.43125848 |
| 73 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42548507 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42106257 |
| 75 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.40775741 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40219643 |
| 77 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.39727647 |
| 78 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.38521641 |
| 79 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.38350610 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37842706 |
| 81 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36488026 |
| 82 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.34274557 |
| 83 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.33279848 |
| 84 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30409469 |
| 85 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.30026136 |
| 86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.29781520 |
| 87 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.29648086 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.29540129 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.29477529 |
| 90 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.29116067 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29115632 |
| 92 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.26415781 |
| 93 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26248672 |
| 94 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26096328 |
| 95 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.25254970 |
| 96 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24634890 |
| 97 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24058814 |
| 98 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.23794923 |
| 99 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.23780805 |
| 100 | MAF_26560356_Chip-Seq_TH2_Human | 1.23256801 |
| 101 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23060697 |
| 102 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.22074547 |
| 103 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21511011 |
| 104 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.20568728 |
| 105 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18383341 |
| 106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18280740 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18243180 |
| 108 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.16703516 |
| 109 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16635507 |
| 110 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15933499 |
| 111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15910290 |
| 112 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.15144963 |
| 113 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14862253 |
| 114 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.14539373 |
| 115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13649732 |
| 116 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.13569108 |
| 117 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.12724998 |
| 118 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.12581075 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.10925668 |
| 120 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09866049 |
| 121 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.09792436 |
| 122 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09578789 |
| 123 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.09489492 |
| 124 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.08910083 |
| 125 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08209631 |
| 126 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.08032778 |
| 127 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.07382903 |
| 128 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06406128 |
| 129 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05920195 |
| 130 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05864741 |
| 131 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.05428861 |
| 132 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05373952 |
| 133 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.04242720 |
| 134 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04117822 |
| 135 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04083178 |
| 136 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.03900191 |
| 137 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03875628 |
| 138 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03471931 |
| 139 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.02762296 |
| 140 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01825449 |
| 141 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01366823 |
| 142 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00582253 |
| 143 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00100501 |
| 144 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00053433 |
| 145 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98402301 |
| 146 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97690080 |
| 147 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96639132 |
| 148 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95070964 |
| 149 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.94416660 |
| 150 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93817331 |
| 151 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93408305 |
| 152 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92550839 |
| 153 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92125159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 4.34199486 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.89902224 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 3.85766592 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.37515530 |
| 5 | MP0000678_abnormal_parathyroid_gland | 3.26524151 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.03694985 |
| 7 | MP0004957_abnormal_blastocyst_morpholog | 3.00596376 |
| 8 | MP0002796_impaired_skin_barrier | 2.87562363 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.81498032 |
| 10 | MP0005174_abnormal_tail_pigmentation | 2.64060239 |
| 11 | MP0010094_abnormal_chromosome_stability | 2.63203077 |
| 12 | MP0002163_abnormal_gland_morphology | 2.59332567 |
| 13 | MP0004858_abnormal_nervous_system | 2.55830061 |
| 14 | MP0009785_altered_susceptibility_to | 2.51496486 |
| 15 | MP0003436_decreased_susceptibility_to | 2.51311470 |
| 16 | MP0003111_abnormal_nucleus_morphology | 2.49498835 |
| 17 | MP0008057_abnormal_DNA_replication | 2.48004929 |
| 18 | MP0005501_abnormal_skin_physiology | 2.44797141 |
| 19 | MP0004185_abnormal_adipocyte_glucose | 2.44600936 |
| 20 | MP0003077_abnormal_cell_cycle | 2.42731456 |
| 21 | MP0000490_abnormal_crypts_of | 2.38946348 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.38357932 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 2.37608871 |
| 24 | MP0001545_abnormal_hematopoietic_system | 2.37608871 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.24856520 |
| 26 | MP0008058_abnormal_DNA_repair | 2.21949276 |
| 27 | MP0003186_abnormal_redox_activity | 2.18011008 |
| 28 | MP0005025_abnormal_response_to | 2.16019376 |
| 29 | MP0002249_abnormal_larynx_morphology | 2.12886373 |
| 30 | MP0000685_abnormal_immune_system | 2.10110971 |
| 31 | MP0001853_heart_inflammation | 2.09398157 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.98127572 |
| 33 | MP0008007_abnormal_cellular_replicative | 1.97735406 |
| 34 | MP0005671_abnormal_response_to | 1.91872996 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.90510126 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.89026845 |
| 37 | MP0001661_extended_life_span | 1.88493589 |
| 38 | MP0003724_increased_susceptibility_to | 1.85871578 |
| 39 | MP0003453_abnormal_keratinocyte_physiol | 1.84859118 |
| 40 | MP0002419_abnormal_innate_immunity | 1.82509772 |
| 41 | MP0002398_abnormal_bone_marrow | 1.82316277 |
| 42 | MP0002139_abnormal_hepatobiliary_system | 1.81527030 |
| 43 | MP0005670_abnormal_white_adipose | 1.78399929 |
| 44 | MP0000858_altered_metastatic_potential | 1.77595931 |
| 45 | MP0005360_urolithiasis | 1.77511233 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.75915188 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.73324402 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.71438762 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 1.70484297 |
| 50 | MP0002822_catalepsy | 1.69474002 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.69436181 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.68945775 |
| 53 | MP0002723_abnormal_immune_serum | 1.68062861 |
| 54 | MP0001819_abnormal_immune_cell | 1.67825644 |
| 55 | MP0001800_abnormal_humoral_immune | 1.67811125 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.65789645 |
| 57 | MP0008260_abnormal_autophagy | 1.65711769 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 1.63664287 |
| 59 | MP0005666_abnormal_adipose_tissue | 1.61670412 |
| 60 | MP0003123_paternal_imprinting | 1.61593919 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.61363292 |
| 62 | MP0002722_abnormal_immune_system | 1.59884525 |
| 63 | MP0001346_abnormal_lacrimal_gland | 1.57583285 |
| 64 | MP0003303_peritoneal_inflammation | 1.57310893 |
| 65 | MP0005083_abnormal_biliary_tract | 1.55426250 |
| 66 | MP0000003_abnormal_adipose_tissue | 1.53149321 |
| 67 | MP0002429_abnormal_blood_cell | 1.52683444 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 1.51754423 |
| 69 | MP0000343_altered_response_to | 1.51612287 |
| 70 | MP0000716_abnormal_immune_system | 1.50409483 |
| 71 | MP0004264_abnormal_extraembryonic_tissu | 1.48580576 |
| 72 | MP0002405_respiratory_system_inflammati | 1.44148290 |
| 73 | MP0000681_abnormal_thyroid_gland | 1.42440480 |
| 74 | MP0005375_adipose_tissue_phenotype | 1.42357041 |
| 75 | MP0002234_abnormal_pharynx_morphology | 1.41431432 |
| 76 | MP0002019_abnormal_tumor_incidence | 1.38596716 |
| 77 | MP0002132_abnormal_respiratory_system | 1.34318952 |
| 78 | MP0000372_irregular_coat_pigmentation | 1.33016361 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 1.32961412 |
| 80 | MP0000313_abnormal_cell_death | 1.29748955 |
| 81 | MP0004147_increased_porphyrin_level | 1.28535623 |
| 82 | MP0006054_spinal_hemorrhage | 1.27900696 |
| 83 | MP0005623_abnormal_meninges_morphology | 1.27492116 |
| 84 | MP0008932_abnormal_embryonic_tissue | 1.27449552 |
| 85 | MP0001845_abnormal_inflammatory_respons | 1.27048353 |
| 86 | MP0006082_CNS_inflammation | 1.26869516 |
| 87 | MP0000015_abnormal_ear_pigmentation | 1.26736227 |
| 88 | MP0001188_hyperpigmentation | 1.25706234 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 1.25285022 |
| 90 | MP0010155_abnormal_intestine_physiology | 1.24904903 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 1.24617098 |
| 92 | MP0000537_abnormal_urethra_morphology | 1.21464660 |
| 93 | MP0000358_abnormal_cell_content/ | 1.21382208 |
| 94 | MP0009643_abnormal_urine_homeostasis | 1.20746713 |
| 95 | MP0005058_abnormal_lysosome_morphology | 1.20713255 |
| 96 | MP0005332_abnormal_amino_acid | 1.19972496 |
| 97 | MP0003172_abnormal_lysosome_physiology | 1.19316271 |
| 98 | MP0002095_abnormal_skin_pigmentation | 1.19191678 |
| 99 | MP0008469_abnormal_protein_level | 1.17922991 |
| 100 | MP0001216_abnormal_epidermal_layer | 1.16322973 |
| 101 | MP0005330_cardiomyopathy | 1.15965830 |
| 102 | MP0004019_abnormal_vitamin_homeostasis | 1.15144244 |
| 103 | MP0000350_abnormal_cell_proliferation | 1.14332468 |
| 104 | MP0002098_abnormal_vibrissa_morphology | 1.13691996 |
| 105 | MP0003191_abnormal_cellular_cholesterol | 1.12061717 |
| 106 | MP0005365_abnormal_bile_salt | 1.11730854 |
| 107 | MP0001666_abnormal_nutrient_absorption | 1.10648957 |
| 108 | MP0000703_abnormal_thymus_morphology | 1.09960772 |
| 109 | MP0003866_abnormal_defecation | 1.09137095 |
| 110 | MP0001663_abnormal_digestive_system | 1.08199851 |
| 111 | MP0004510_myositis | 1.04537869 |
| 112 | MP0010030_abnormal_orbit_morphology | 1.03578307 |
| 113 | MP0001873_stomach_inflammation | 1.01774934 |
| 114 | MP0002006_tumorigenesis | 1.00515199 |
| 115 | MP0003786_premature_aging | 1.00475373 |
| 116 | MP0004233_abnormal_muscle_weight | 0.99802618 |
| 117 | MP0001348_abnormal_lacrimal_gland | 0.99629452 |
| 118 | MP0001790_abnormal_immune_system | 0.99338278 |
| 119 | MP0005387_immune_system_phenotype | 0.99338278 |
| 120 | MP0009840_abnormal_foam_cell | 0.98259458 |
| 121 | MP0001849_ear_inflammation | 0.97824068 |
| 122 | MP0003315_abnormal_perineum_morphology | 0.97448267 |
| 123 | MP0002166_altered_tumor_susceptibility | 0.97446850 |
| 124 | MP0003448_altered_tumor_morphology | 0.97195297 |
| 125 | MP0005076_abnormal_cell_differentiation | 0.95463884 |
| 126 | MP0001727_abnormal_embryo_implantation | 0.94880758 |
| 127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94465210 |
| 128 | MP0005266_abnormal_metabolism | 0.92881767 |
| 129 | MP0001986_abnormal_taste_sensitivity | 0.91072884 |
| 130 | MP0000477_abnormal_intestine_morphology | 0.90631464 |
| 131 | MP0010307_abnormal_tumor_latency | 0.90470246 |
| 132 | MP0003879_abnormal_hair_cell | 0.89799431 |
| 133 | MP0006292_abnormal_olfactory_placode | 0.89638958 |
| 134 | MP0000538_abnormal_urinary_bladder | 0.89602214 |
| 135 | MP0000467_abnormal_esophagus_morphology | 0.89390122 |
| 136 | MP0001533_abnormal_skeleton_physiology | 0.88866772 |
| 137 | MP0004782_abnormal_surfactant_physiolog | 0.88791968 |
| 138 | MP0004947_skin_inflammation | 0.88092927 |
| 139 | MP0001730_embryonic_growth_arrest | 0.86405697 |
| 140 | MP0009053_abnormal_anal_canal | 0.85348598 |
| 141 | MP0005319_abnormal_enzyme/_coenzyme | 0.84965974 |
| 142 | MP0005636_abnormal_mineral_homeostasis | 0.84583284 |
| 143 | MP0001664_abnormal_digestion | 0.83613511 |
| 144 | MP0009931_abnormal_skin_appearance | 0.83358722 |
| 145 | MP0000371_diluted_coat_color | 0.80836293 |
| 146 | MP0001881_abnormal_mammary_gland | 0.80364216 |
| 147 | MP0001919_abnormal_reproductive_system | 0.80262786 |
| 148 | MP0002089_abnormal_postnatal_growth/wei | 0.79596824 |
| 149 | MP0000750_abnormal_muscle_regeneration | 0.78353952 |
| 150 | MP0000747_muscle_weakness | 0.78209281 |
| 151 | MP0008873_increased_physiological_sensi | 0.77815121 |
| 152 | MP0010771_integument_phenotype | 0.77472406 |
| 153 | MP0003828_pulmonary_edema | 0.76626547 |
| 154 | MP0002332_abnormal_exercise_endurance | 0.76494991 |
| 155 | MP0000013_abnormal_adipose_tissue | 0.75984493 |
| 156 | MP0002080_prenatal_lethality | 0.74991585 |
| 157 | MP0009764_decreased_sensitivity_to | 0.71709107 |
| 158 | MP0002075_abnormal_coat/hair_pigmentati | 0.71167189 |
| 159 | MP0005376_homeostasis/metabolism_phenot | 0.70998843 |
| 160 | MP0001764_abnormal_homeostasis | 0.70102458 |
| 161 | MP0000609_abnormal_liver_physiology | 0.70090408 |
| 162 | MP0000462_abnormal_digestive_system | 0.69755339 |
| 163 | MP0005023_abnormal_wound_healing | 0.69623788 |
| 164 | MP0003718_maternal_effect | 0.67287742 |
| 165 | MP0002138_abnormal_hepatobiliary_system | 0.64870957 |
| 166 | MP0003183_abnormal_peptide_metabolism | 0.64624142 |
| 167 | MP0000367_abnormal_coat/_hair | 0.64309308 |
| 168 | MP0000465_gastrointestinal_hemorrhage | 0.64220229 |
| 169 | MP0005166_decreased_susceptibility_to | 0.63729921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.85641003 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 6.69866306 |
| 3 | Reticulocytopenia (HP:0001896) | 6.12742026 |
| 4 | Pallor (HP:0000980) | 4.59079337 |
| 5 | Macrocytic anemia (HP:0001972) | 4.24809019 |
| 6 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.05519671 |
| 7 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.05519671 |
| 8 | Aplastic anemia (HP:0001915) | 3.93914354 |
| 9 | Hepatocellular necrosis (HP:0001404) | 3.72523586 |
| 10 | Ragged-red muscle fibers (HP:0003200) | 3.68927592 |
| 11 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.54600734 |
| 12 | Mitochondrial inheritance (HP:0001427) | 3.53560576 |
| 13 | Congenital malformation of the right heart (HP:0011723) | 3.51388863 |
| 14 | Double outlet right ventricle (HP:0001719) | 3.51388863 |
| 15 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.48670324 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.41589424 |
| 17 | Acute necrotizing encephalopathy (HP:0006965) | 3.38275722 |
| 18 | Truncus arteriosus (HP:0001660) | 3.36825456 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.31813254 |
| 20 | Hepatic necrosis (HP:0002605) | 3.31560495 |
| 21 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.26788867 |
| 22 | Increased CSF lactate (HP:0002490) | 3.26007758 |
| 23 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.16279220 |
| 24 | Thrombocytosis (HP:0001894) | 3.14987591 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.14593491 |
| 26 | Lipid accumulation in hepatocytes (HP:0006561) | 3.11985571 |
| 27 | Hyperthyroidism (HP:0000836) | 3.10684711 |
| 28 | Increased intramyocellular lipid droplets (HP:0012240) | 3.10316522 |
| 29 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.08217563 |
| 30 | Reduced antithrombin III activity (HP:0001976) | 3.00068665 |
| 31 | Increased serum lactate (HP:0002151) | 2.99933045 |
| 32 | Exertional dyspnea (HP:0002875) | 2.97812102 |
| 33 | Multiple enchondromatosis (HP:0005701) | 2.96577701 |
| 34 | Type I transferrin isoform profile (HP:0003642) | 2.95503036 |
| 35 | Stridor (HP:0010307) | 2.95129559 |
| 36 | Petechiae (HP:0000967) | 2.94195963 |
| 37 | Increased muscle lipid content (HP:0009058) | 2.86832935 |
| 38 | Abnormality of reticulocytes (HP:0004312) | 2.86668517 |
| 39 | Myopathic facies (HP:0002058) | 2.83962340 |
| 40 | Recurrent bacterial skin infections (HP:0005406) | 2.82064104 |
| 41 | Abnormality of macrophages (HP:0004311) | 2.81771541 |
| 42 | IgM deficiency (HP:0002850) | 2.78689625 |
| 43 | Acute encephalopathy (HP:0006846) | 2.72551501 |
| 44 | Increased serum ferritin (HP:0003281) | 2.72014035 |
| 45 | Broad distal phalanx of finger (HP:0009836) | 2.70618600 |
| 46 | Progressive macrocephaly (HP:0004481) | 2.61789287 |
| 47 | Testicular atrophy (HP:0000029) | 2.60854915 |
| 48 | Hypertensive crisis (HP:0100735) | 2.60326389 |
| 49 | Septate vagina (HP:0001153) | 2.58572219 |
| 50 | Agnosia (HP:0010524) | 2.58414240 |
| 51 | Poor head control (HP:0002421) | 2.54760973 |
| 52 | Seborrheic dermatitis (HP:0001051) | 2.54289683 |
| 53 | Pancytopenia (HP:0001876) | 2.53464344 |
| 54 | Oral leukoplakia (HP:0002745) | 2.52932657 |
| 55 | Lactic acidosis (HP:0003128) | 2.52796263 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.52257834 |
| 57 | Hypokinesia (HP:0002375) | 2.50730919 |
| 58 | Achilles tendon contracture (HP:0001771) | 2.49099464 |
| 59 | Exercise intolerance (HP:0003546) | 2.48957893 |
| 60 | Stomatitis (HP:0010280) | 2.47994742 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.47064116 |
| 62 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.45647809 |
| 63 | Unilateral renal agenesis (HP:0000122) | 2.45438318 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.40640890 |
| 65 | Renal Fanconi syndrome (HP:0001994) | 2.40050457 |
| 66 | Abnormal protein glycosylation (HP:0012346) | 2.36938527 |
| 67 | Abnormal glycosylation (HP:0012345) | 2.36938527 |
| 68 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.36938527 |
| 69 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.36938527 |
| 70 | Respiratory difficulties (HP:0002880) | 2.36718172 |
| 71 | 3-Methylglutaconic aciduria (HP:0003535) | 2.34281229 |
| 72 | Prolonged bleeding time (HP:0003010) | 2.34051012 |
| 73 | Microretrognathia (HP:0000308) | 2.33771354 |
| 74 | Birth length less than 3rd percentile (HP:0003561) | 2.33378705 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.32416290 |
| 76 | Cholecystitis (HP:0001082) | 2.32416290 |
| 77 | Microvesicular hepatic steatosis (HP:0001414) | 2.30095572 |
| 78 | Prolonged neonatal jaundice (HP:0006579) | 2.28634995 |
| 79 | Abnormality of the Achilles tendon (HP:0005109) | 2.27928586 |
| 80 | Severe visual impairment (HP:0001141) | 2.25027506 |
| 81 | Respiratory failure (HP:0002878) | 2.24536400 |
| 82 | Bulbar palsy (HP:0001283) | 2.24430657 |
| 83 | Gout (HP:0001997) | 2.21664010 |
| 84 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.19688062 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.18020287 |
| 86 | Nausea (HP:0002018) | 2.16417373 |
| 87 | Hyperparathyroidism (HP:0000843) | 2.15882179 |
| 88 | Transposition of the great arteries (HP:0001669) | 2.14696901 |
| 89 | Abnormal connection of the cardiac segments (HP:0011545) | 2.14696901 |
| 90 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.14696901 |
| 91 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.13661735 |
| 92 | Absent thumb (HP:0009777) | 2.11204421 |
| 93 | Dicarboxylic aciduria (HP:0003215) | 2.10030976 |
| 94 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.10030976 |
| 95 | Abnormality of the anterior horn cell (HP:0006802) | 2.09945088 |
| 96 | Degeneration of anterior horn cells (HP:0002398) | 2.09945088 |
| 97 | Breast hypoplasia (HP:0003187) | 2.08532632 |
| 98 | Pulmonary fibrosis (HP:0002206) | 2.06427597 |
| 99 | Muscle fiber atrophy (HP:0100295) | 2.05842026 |
| 100 | Abnormality of the umbilical cord (HP:0010881) | 2.04642520 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.04059118 |
| 102 | Abnormality of the gallbladder (HP:0005264) | 2.03389465 |
| 103 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.02802740 |
| 104 | Villous atrophy (HP:0011473) | 2.02802740 |
| 105 | Malnutrition (HP:0004395) | 2.01500503 |
| 106 | Abnormal hemoglobin (HP:0011902) | 2.00936791 |
| 107 | Squamous cell carcinoma (HP:0002860) | 2.00500739 |
| 108 | Trismus (HP:0000211) | 1.99998634 |
| 109 | Rough bone trabeculation (HP:0100670) | 1.98584887 |
| 110 | Distal lower limb muscle weakness (HP:0009053) | 1.97901138 |
| 111 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97655761 |
| 112 | Progressive muscle weakness (HP:0003323) | 1.96800415 |
| 113 | Chronic otitis media (HP:0000389) | 1.96750609 |
| 114 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.96553538 |
| 115 | Obstructive lung disease (HP:0006536) | 1.96526377 |
| 116 | Chronic obstructive pulmonary disease (HP:0006510) | 1.96526377 |
| 117 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.93593698 |
| 118 | Single umbilical artery (HP:0001195) | 1.93593698 |
| 119 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.93593698 |
| 120 | Cholelithiasis (HP:0001081) | 1.92464606 |
| 121 | Axonal loss (HP:0003447) | 1.91447340 |
| 122 | Emotional lability (HP:0000712) | 1.90453512 |
| 123 | Abnormality of the aortic arch (HP:0012303) | 1.89548888 |
| 124 | Myelodysplasia (HP:0002863) | 1.89519141 |
| 125 | Hypoplastic left heart (HP:0004383) | 1.88217029 |
| 126 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.87680131 |
| 127 | Opisthotonus (HP:0002179) | 1.86621770 |
| 128 | Abnormal trabecular bone morphology (HP:0100671) | 1.86327677 |
| 129 | Ulnar bowing (HP:0003031) | 1.86286229 |
| 130 | 11 pairs of ribs (HP:0000878) | 1.84645521 |
| 131 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84231129 |
| 132 | Cleft eyelid (HP:0000625) | 1.84157593 |
| 133 | Abnormality of T cell physiology (HP:0011840) | 1.83320012 |
| 134 | Lymphoma (HP:0002665) | 1.82711673 |
| 135 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.81379764 |
| 136 | Basal ganglia calcification (HP:0002135) | 1.81033883 |
| 137 | Abnormality of glycolysis (HP:0004366) | 1.80417600 |
| 138 | Abnormality of glycolipid metabolism (HP:0010969) | 1.79912565 |
| 139 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.79912565 |
| 140 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.79912565 |
| 141 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.79860811 |
| 142 | Thin bony cortex (HP:0002753) | 1.79807825 |
| 143 | Vertebral compression fractures (HP:0002953) | 1.78572106 |
| 144 | Cutaneous photosensitivity (HP:0000992) | 1.78541996 |
| 145 | Selective tooth agenesis (HP:0001592) | 1.78069169 |
| 146 | Epistaxis (HP:0000421) | 1.78048746 |
| 147 | Personality changes (HP:0000751) | 1.76941783 |
| 148 | Abnormality of the tricuspid valve (HP:0001702) | 1.76891787 |
| 149 | Cerebral edema (HP:0002181) | 1.76173123 |
| 150 | Myositis (HP:0100614) | 1.76153237 |
| 151 | Premature ovarian failure (HP:0008209) | 1.76128009 |
| 152 | Growth hormone excess (HP:0000845) | 1.75304477 |
| 153 | Abdominal distention (HP:0003270) | 1.75290677 |
| 154 | Vaginal fistula (HP:0004320) | 1.75274471 |
| 155 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.75263246 |
| 156 | Hypergonadotropic hypogonadism (HP:0000815) | 1.75104159 |
| 157 | Recurrent viral infections (HP:0004429) | 1.75051498 |
| 158 | Premature graying of hair (HP:0002216) | 1.74742404 |
| 159 | Abnormal platelet function (HP:0011869) | 1.74338925 |
| 160 | Impaired platelet aggregation (HP:0003540) | 1.74338925 |
| 161 | CNS demyelination (HP:0007305) | 1.73781481 |
| 162 | Type 2 muscle fiber atrophy (HP:0003554) | 1.73431985 |
| 163 | Rectal prolapse (HP:0002035) | 1.71365728 |
| 164 | Hypoparathyroidism (HP:0000829) | 1.71264749 |
| 165 | Nonimmune hydrops fetalis (HP:0001790) | 1.70960604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.87533689 |
| 2 | TLK1 | 4.52320953 |
| 3 | TRIB3 | 4.29051256 |
| 4 | SMG1 | 3.38667789 |
| 5 | STK16 | 3.28190079 |
| 6 | PIM2 | 3.17311658 |
| 7 | WEE1 | 2.97793013 |
| 8 | BUB1 | 2.66899652 |
| 9 | VRK2 | 2.48487493 |
| 10 | EIF2AK3 | 2.23442828 |
| 11 | VRK1 | 2.19178402 |
| 12 | MAP3K11 | 2.15944967 |
| 13 | EIF2AK1 | 2.05516582 |
| 14 | SIK1 | 1.99287349 |
| 15 | SCYL2 | 1.95469504 |
| 16 | ACVR1B | 1.89821531 |
| 17 | KIT | 1.87236862 |
| 18 | MAP4K1 | 1.81152736 |
| 19 | MST1R | 1.79708378 |
| 20 | ICK | 1.66459911 |
| 21 | BLK | 1.66198071 |
| 22 | SRPK1 | 1.63577245 |
| 23 | CDC7 | 1.61761209 |
| 24 | TESK2 | 1.60974266 |
| 25 | MAP3K12 | 1.53781583 |
| 26 | PRPF4B | 1.53295841 |
| 27 | FLT3 | 1.51234165 |
| 28 | TAOK2 | 1.45799348 |
| 29 | RPS6KB2 | 1.45048609 |
| 30 | KDR | 1.42561644 |
| 31 | CDK7 | 1.42123708 |
| 32 | LRRK2 | 1.31993126 |
| 33 | TBK1 | 1.31802136 |
| 34 | MATK | 1.30446419 |
| 35 | TAOK1 | 1.26800754 |
| 36 | CDK19 | 1.26700976 |
| 37 | DYRK3 | 1.23073956 |
| 38 | BTK | 1.23072839 |
| 39 | TEC | 1.21923886 |
| 40 | BCKDK | 1.21127249 |
| 41 | ABL2 | 1.18041061 |
| 42 | PIM1 | 1.15697261 |
| 43 | PRKG2 | 1.14943800 |
| 44 | TYK2 | 1.13784410 |
| 45 | IRAK4 | 1.11107873 |
| 46 | ZAP70 | 1.07998385 |
| 47 | IRAK3 | 1.05982408 |
| 48 | IRAK2 | 1.03850786 |
| 49 | BRSK2 | 1.03849806 |
| 50 | MAPK11 | 1.03475944 |
| 51 | PRKD3 | 1.03315009 |
| 52 | JAK3 | 1.03128457 |
| 53 | MAP3K8 | 1.00505984 |
| 54 | IKBKB | 0.99376599 |
| 55 | ERN1 | 0.99033185 |
| 56 | MAP3K1 | 0.98949145 |
| 57 | PRKCI | 0.98711184 |
| 58 | RPS6KA4 | 0.97781612 |
| 59 | TGFBR1 | 0.97414310 |
| 60 | TSSK6 | 0.97219514 |
| 61 | NME1 | 0.95855984 |
| 62 | SYK | 0.95329408 |
| 63 | MAPKAPK3 | 0.95270559 |
| 64 | DAPK3 | 0.94820285 |
| 65 | LMTK2 | 0.94754819 |
| 66 | CSNK1G3 | 0.93250238 |
| 67 | MAP2K2 | 0.92551830 |
| 68 | PLK1 | 0.91395959 |
| 69 | MAP3K3 | 0.90095106 |
| 70 | MAP2K6 | 0.87925005 |
| 71 | ATR | 0.87502324 |
| 72 | PKN2 | 0.85497035 |
| 73 | CSF1R | 0.84778690 |
| 74 | EIF2AK2 | 0.82838654 |
| 75 | PDPK1 | 0.82484268 |
| 76 | ARAF | 0.82367146 |
| 77 | PBK | 0.80724307 |
| 78 | ILK | 0.79119346 |
| 79 | PAK4 | 0.78559905 |
| 80 | AURKA | 0.78245203 |
| 81 | LYN | 0.77483498 |
| 82 | CDK8 | 0.76170840 |
| 83 | TESK1 | 0.75735933 |
| 84 | ADRBK2 | 0.75205932 |
| 85 | FES | 0.73019920 |
| 86 | PTK6 | 0.72425960 |
| 87 | RPS6KA2 | 0.71388892 |
| 88 | MKNK1 | 0.71289568 |
| 89 | STK10 | 0.70153273 |
| 90 | AURKB | 0.69125250 |
| 91 | GRK6 | 0.68770851 |
| 92 | RIPK4 | 0.68151316 |
| 93 | MAP3K10 | 0.66809933 |
| 94 | MUSK | 0.66445766 |
| 95 | PLK4 | 0.65001524 |
| 96 | LIMK1 | 0.64186215 |
| 97 | CSNK1A1L | 0.64006216 |
| 98 | NEK2 | 0.62880580 |
| 99 | PRKD2 | 0.62375670 |
| 100 | MKNK2 | 0.61498551 |
| 101 | CDK4 | 0.60972259 |
| 102 | PAK1 | 0.60792636 |
| 103 | TAF1 | 0.60242994 |
| 104 | CDK12 | 0.59225860 |
| 105 | RPS6KL1 | 0.58701661 |
| 106 | RPS6KC1 | 0.58701661 |
| 107 | AKT2 | 0.58644638 |
| 108 | LCK | 0.58052691 |
| 109 | TXK | 0.57826981 |
| 110 | CSNK2A1 | 0.57415542 |
| 111 | MAP2K7 | 0.57409945 |
| 112 | TTN | 0.56961810 |
| 113 | RAF1 | 0.56947822 |
| 114 | CSNK2A2 | 0.56739824 |
| 115 | DAPK1 | 0.56303832 |
| 116 | MAPK12 | 0.55963762 |
| 117 | MAP2K3 | 0.55829953 |
| 118 | STK4 | 0.55152426 |
| 119 | PDK2 | 0.54720239 |
| 120 | BRSK1 | 0.54342349 |
| 121 | EPHA2 | 0.54244180 |
| 122 | BRAF | 0.54036038 |
| 123 | CAMK2G | 0.53830132 |
| 124 | BMX | 0.50772890 |
| 125 | HIPK2 | 0.48721940 |
| 126 | IKBKE | 0.46750393 |
| 127 | YES1 | 0.45220846 |
| 128 | MAPK4 | 0.45135423 |
| 129 | RPS6KA6 | 0.42603678 |
| 130 | CHEK2 | 0.41992881 |
| 131 | MTOR | 0.41003739 |
| 132 | CSNK1G1 | 0.40757560 |
| 133 | TGFBR2 | 0.39861239 |
| 134 | PRKCD | 0.39315744 |
| 135 | FGFR4 | 0.38828625 |
| 136 | TNK2 | 0.38190471 |
| 137 | PTK2 | 0.36898488 |
| 138 | PHKG1 | 0.36621181 |
| 139 | PHKG2 | 0.36621181 |
| 140 | CSNK1G2 | 0.34801510 |
| 141 | RPS6KA5 | 0.34161452 |
| 142 | MOS | 0.33935758 |
| 143 | MAP3K6 | 0.33608196 |
| 144 | GRK7 | 0.33231816 |
| 145 | CDK9 | 0.31702355 |
| 146 | TNIK | 0.31208300 |
| 147 | EEF2K | 0.31119938 |
| 148 | PDK1 | 0.30390576 |
| 149 | CDC42BPA | 0.30168428 |
| 150 | TAOK3 | 0.29645858 |
| 151 | RIPK1 | 0.29600549 |
| 152 | MAPKAPK2 | 0.28356093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 6.04368936 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.31658673 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.35100292 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.25119399 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.03634575 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.90924759 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.67219822 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.63272122 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.58921229 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.52656085 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.48710292 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.44063847 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.34695335 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09383172 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.06675367 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.87241320 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.84071614 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.81553747 |
| 19 | RNA transport_Homo sapiens_hsa03013 | 1.68868623 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.59166307 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53641973 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.52964110 |
| 23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.51158026 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.50760771 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.46118704 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.45341858 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41668674 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.40056496 |
| 29 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.37562501 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31406680 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29018297 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.28509638 |
| 33 | Bladder cancer_Homo sapiens_hsa05219 | 1.27001807 |
| 34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.22063030 |
| 35 | Cell cycle_Homo sapiens_hsa04110 | 1.15184302 |
| 36 | Purine metabolism_Homo sapiens_hsa00230 | 1.14908877 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.13139076 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10808849 |
| 39 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09750601 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.08372808 |
| 41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.08059777 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.07836556 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07178191 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06888605 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.05644859 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00000720 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99338109 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96514797 |
| 49 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.91929834 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91212379 |
| 51 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89139678 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88157695 |
| 53 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85858011 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.85840397 |
| 55 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.82673917 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.82200712 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81278012 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80319814 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78627490 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.78307833 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73786174 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73724974 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72996366 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72134089 |
| 65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71763471 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70326474 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.68827018 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68430340 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67819374 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66865587 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.66720902 |
| 72 | Alcoholism_Homo sapiens_hsa05034 | 0.66083051 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65503212 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63693462 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.62803705 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62473478 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62454470 |
| 78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61442286 |
| 79 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61256851 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61093174 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.60280264 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60079795 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59976938 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 0.59291266 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57892217 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55597019 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55223360 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54269206 |
| 89 | Tuberculosis_Homo sapiens_hsa05152 | 0.53322831 |
| 90 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52335676 |
| 91 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.52123875 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51824311 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.50751947 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50417177 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50331423 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49628535 |
| 97 | Carbon metabolism_Homo sapiens_hsa01200 | 0.49388947 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49263302 |
| 99 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47375972 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46940944 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.45802515 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.45530913 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45289667 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45262699 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44884073 |
| 106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.44577932 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.44257175 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43876122 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43123362 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.42967243 |
| 111 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41881026 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.41628526 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41342511 |
| 114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41245946 |
| 115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40212247 |
| 116 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.38874409 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.38413018 |
| 118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37564074 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37441197 |
| 120 | Allograft rejection_Homo sapiens_hsa05330 | 0.36730649 |
| 121 | Hepatitis B_Homo sapiens_hsa05161 | 0.36004480 |
| 122 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35085067 |
| 123 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.34381175 |
| 124 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.34147935 |
| 125 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33054318 |
| 126 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.32510454 |
| 127 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32001798 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30998501 |
| 129 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30377725 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30188582 |
| 131 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30065574 |
| 132 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.29897736 |
| 133 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.29793615 |
| 134 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.29671544 |
| 135 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.29653891 |
| 136 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.28715452 |
| 137 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27466408 |
| 138 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.27142280 |
| 139 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24918082 |
| 140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.23139493 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22447455 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20574675 |
| 143 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19171029 |

